Fruzsina Molnár-Gábor (Dr. iur.) is research group leader at the Heidelberg Academy of Sciences and Humanities and senior lecturer at the Faculty of Law, University of Heidelberg, Germany. Her research focuses on the regulation of biomedicine and biotechnology, including the fields of data law, medical law, international law, and the law of the European Union. She is member of the Ethics Working Group of the Human Cell Atlas, is affiliated with the Ethics and Governance Committee of the International Cancer Genome Consortium – Accelerating Research in Genomic Oncology, and member of the Junge Akademie of the Berlin-Brandenburg Academy of Sciences and Humanities and the Leopoldina in Germany. Molnár-Gábor is co-editor of the monthly briefs published by the General Data Protection Regulation Forum of the Global Alliance for Genomics and Health. She represents Germany in the EU’s 1+ Million Genomes Initiative in the working group on ethical, legal and social issues. She is co-leader of the ethico-legal work package in the EU-Canada flagship collaboration EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. In Germany, she is in charge of establishing the legal framework for the country’s -omics data research infrastructure. She has received the Manfred-Fuchs Prize, the promotion award of the VG Wort for her PhD, the Young Scholars Award of the Research Network on EU Administrative Law and the Heinz Maier-Leibnitz Prize 2020 for her interdisciplinary research. Her writings have been published by Brill, BMC Medical Ethics, Nature, Oxford University Press, Routledge, and Springer.